FDA Approves Genentech's Zelboraf, the First-Ever Drug to Treat Specific Rare Blood Disease
People diagnosed with the rare blood disorder known as Erdheim-Chester disease have a new treatment option. Source: BioSpace
People diagnosed with the rare blood disorder known as Erdheim-Chester disease have a new treatment option. Source: BioSpace
The jobs are being cut because Roche is moving Swiss packaging ops to CMO-divested sites. Source: BioSpace
Shares of Haemonetics are up nearly 10 percent this morning after the company announced it was cutting about 11 percent of its workforce in a restructuring effort. Source: BioSpace
Varian said it will replace linear accelerators in the oncology departments of Rigshospitalet and Herlev Hospital with 15 advanced Varian TrueBeam and Halcyon treatment machines and two ViewRay MRIdian MR-Guided…
Exicure announced it had closed on $11.2M in private financing. Source: BioSpace
A little more than two years after acquiring Sprout, Valeant is selling off the developer of the female sex drive drug Addyi. Source: BioSpace
Shares of Teva are up more than 5 percent this morning after Israeli media reported billionaire businessman Len Blavatnik is considering taking a large stock position in the pharma giant.…
The round was led by new investor Abingworth with participation from another new investor, 5AM Ventures, LSP and Versant Ventures. Source: BioSpace
Shares of TherapeuticsMD have shot up more than 51 percent in morning trading after the FDA reversed course on its rejection of that company's vaginal pain medication. Source: BioSpace
Two of the top companies in the field are German-based CureVac and U.S.-based Moderna Therapeutics. Source: BioSpace